ConforMIS, Inc. (NASDAQ:CFMS) is expected to report third quarter earnings results, after market close, on Wednesday 4th November 2020.
Analysts polled by Thomson Reuters anticipate third quarter loss of $ 0.12 per share from revenue of $ 14.42 million.
Looking ahead, the full year loss are expected at $ 0.38 per share on the revenues of $ 70.77 million.
The Company Outlook
Revenue for 3Q20 are expected in a range of $ 16.10 million ~ $ 16.10 million
Click Here For More Historical Outlooks Of ConforMIS, Inc.
Previous Quarter Performance
ConforMIS, Inc. revealed loss for the second quarter of $ 0.03 per share, from the revenue of $ 19.47 million. Wall street analysts are predicting, CFMS to report 2Q20 loss of $ 0.10 per share from revenue of $ 12.43 million. The bottom line results beat street analysts by $ 0.07 or 70.00 percent, at the same time, top line results outshined analysts by $ 7.04 million or 56.64 percent.
Stock Performance
Shares of ConforMIS, Inc. traded up $ 0.00 or 0.62 percent on Tuesday, reaching $ 0.68 with volume of 256.20 thousand shares. ConforMIS, Inc. has traded high as $ 0.69 and has cracked $ 0.65 on the downward trend
According to the previous trading day, closing price of $ 0.68, representing a 36.00 % increase from the 52 week low of $ 0.50 and a 69.78 % decrease over the 52 week high of $ 2.25.
The company has a market capital of $ 52.75 million and is part of the Healthcare sector and Medical Devices industry.
Conference Call
ConforMIS, Inc. will be hosting a conference call at 4:30 PM eastern time on 4th November 2020, to discuss its 3Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.conformis.com
Conformis, Inc., a medical technology company, develops, manufactures, and sells joint replacement implants. The company offers customized knee replacement products, including iTotal CR, a cruciate-retaining product; iTotal PS, a posterior cruciate ligament substituting product; iDuo, a customized bicompartmental knee replacement system; and iUni, a customized unicompartmental knee replacement product to treat the medial or lateral compartment of the knee. It also provides Conformis Hip System, a hip replacement product; and iJigs, a customized single-use patient-specific instrumentation.
